Biotech Values

[Biowatch]

Cramer's pushed GILD all year, in lightning rounds on Mad Money saying it's a better pick than other biotech stocks people ask about, and in his other TheStreet.com outlets.

GILD is down less than 2% since the beginning of the calendar year, which is better than market average.

http://finance.yahoo.com/q/h?s=GILD

http://www.google.com/#hl=en&q=thestreet.com+cramer+gilead+2009&btnG=Google+Search&aq=f&oq=thestreet.com+cramer+gilead+2009&aqi=&fp=KxYPMM6r3XA